171 related articles for article (PubMed ID: 33391258)
1. Augmenting E Protein Activity Impairs cDC2 Differentiation at the Pre-cDC Stage.
Bajana S; Thomas K; Georgescu C; Zhao Y; Wren JD; Kovats S; Sun XH
Front Immunol; 2020; 11():577718. PubMed ID: 33391258
[TBL] [Abstract][Full Text] [Related]
2. IRF4 and IRF8 Act in CD11c+ Cells To Regulate Terminal Differentiation of Lung Tissue Dendritic Cells.
Bajaña S; Turner S; Paul J; Ainsua-Enrich E; Kovats S
J Immunol; 2016 Feb; 196(4):1666-77. PubMed ID: 26746189
[TBL] [Abstract][Full Text] [Related]
3. Cell-autonomous FLT3L shedding via ADAM10 mediates conventional dendritic cell development in mouse spleen.
Fujita K; Chakarov S; Kobayashi T; Sakamoto K; Voisin B; Duan K; Nakagawa T; Horiuchi K; Amagai M; Ginhoux F; Nagao K
Proc Natl Acad Sci U S A; 2019 Jul; 116(29):14714-14723. PubMed ID: 31262819
[TBL] [Abstract][Full Text] [Related]
4. Allograft Inflammatory Factor-1 Governs Hematopoietic Stem Cell Differentiation Into cDC1 and Monocyte-Derived Dendritic Cells Through IRF8 and RelB
Elizondo DM; Brandy NZD; da Silva RLL; Haddock NL; Kacsinta AD; de Moura TR; Lipscomb MW
Front Immunol; 2019; 10():173. PubMed ID: 30800127
[TBL] [Abstract][Full Text] [Related]
5. Single cell RNA-Seq reveals pre-cDCs fate determined by transcription factor combinatorial dose.
Ma W; Lee J; Backenroth D; Zhou YJ; Bush E; Sims P; Liu K; Shen Y
BMC Mol Cell Biol; 2019 Jun; 20(1):20. PubMed ID: 31253076
[TBL] [Abstract][Full Text] [Related]
6. IRF8 deficiency induces the transcriptional, functional, and epigenetic reprogramming of cDC1 into the cDC2 lineage.
Lança T; Ungerbäck J; Da Silva C; Joeris T; Ahmadi F; Vandamme J; Svensson-Frej M; Mowat AM; Kotarsky K; Sigvardsson M; Agace WW
Immunity; 2022 Aug; 55(8):1431-1447.e11. PubMed ID: 35830859
[TBL] [Abstract][Full Text] [Related]
7. Type 1 conventional dendritic cell fate and function are controlled by DC-SCRIPT.
Zhang S; Coughlan HD; Ashayeripanah M; Seizova S; Kueh AJ; Brown DV; Cao W; Jacquelot N; D'Amico A; Lew AM; Zhan Y; Tonkin CJ; Villadangos JA; Smyth GK; Chopin M; Nutt SL
Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33811060
[TBL] [Abstract][Full Text] [Related]
8. Merocytic Dendritic Cells Compose a Conventional Dendritic Cell Subset with Low Metabolic Activity.
Audiger C; Fois A; Thomas AL; Janssen E; Pelletier M; Lesage S
J Immunol; 2020 Jul; 205(1):121-132. PubMed ID: 32461238
[TBL] [Abstract][Full Text] [Related]
9. IRF8 regulates B-cell lineage specification, commitment, and differentiation.
Wang H; Lee CH; Qi C; Tailor P; Feng J; Abbasi S; Atsumi T; Morse HC
Blood; 2008 Nov; 112(10):4028-38. PubMed ID: 18799728
[TBL] [Abstract][Full Text] [Related]
10. High Amount of Transcription Factor IRF8 Engages AP1-IRF Composite Elements in Enhancers to Direct Type 1 Conventional Dendritic Cell Identity.
Kim S; Bagadia P; Anderson DA; Liu TT; Huang X; Theisen DJ; O'Connor KW; Ohara RA; Iwata A; Murphy TL; Murphy KM
Immunity; 2020 Oct; 53(4):759-774.e9. PubMed ID: 32795402
[TBL] [Abstract][Full Text] [Related]
11. IRF8 and BATF3 interaction enhances the cDC1 specific Pfkfb3 gene expression.
Chauhan KS; Das A; Jaiswal H; Saha I; Kaushik M; Patel VK; Tailor P
Cell Immunol; 2022 Jan; 371():104468. PubMed ID: 34968772
[TBL] [Abstract][Full Text] [Related]
12. Single-cell analyses reveal the clonal and molecular aetiology of Flt3L-induced emergency dendritic cell development.
Lin DS; Tian L; Tomei S; Amann-Zalcenstein D; Baldwin TM; Weber TS; Schreuder J; Stonehouse OJ; Rautela J; Huntington ND; Taoudi S; Ritchie ME; Hodgkin PD; Ng AP; Nutt SL; Naik SH
Nat Cell Biol; 2021 Mar; 23(3):219-231. PubMed ID: 33649477
[TBL] [Abstract][Full Text] [Related]
13. Batf3 maintains autoactivation of Irf8 for commitment of a CD8α(+) conventional DC clonogenic progenitor.
Grajales-Reyes GE; Iwata A; Albring J; Wu X; Tussiwand R; Kc W; Kretzer NM; Briseño CG; Durai V; Bagadia P; Haldar M; Schönheit J; Rosenbauer F; Murphy TL; Murphy KM
Nat Immunol; 2015 Jul; 16(7):708-17. PubMed ID: 26054719
[TBL] [Abstract][Full Text] [Related]
14. Cryptic activation of an Irf8 enhancer governs cDC1 fate specification.
Durai V; Bagadia P; Granja JM; Satpathy AT; Kulkarni DH; Davidson JT; Wu R; Patel SJ; Iwata A; Liu TT; Huang X; Briseño CG; Grajales-Reyes GE; Wöhner M; Tagoh H; Kee BL; Newberry RD; Busslinger M; Chang HY; Murphy TL; Murphy KM
Nat Immunol; 2019 Sep; 20(9):1161-1173. PubMed ID: 31406378
[TBL] [Abstract][Full Text] [Related]
15. Differential IRF8 Transcription Factor Requirement Defines Two Pathways of Dendritic Cell Development in Humans.
Cytlak U; Resteu A; Pagan S; Green K; Milne P; Maisuria S; McDonald D; Hulme G; Filby A; Carpenter B; Queen R; Hambleton S; Hague R; Lango Allen H; Thaventhiran JED; Doody G; Collin M; Bigley V
Immunity; 2020 Aug; 53(2):353-370.e8. PubMed ID: 32735845
[TBL] [Abstract][Full Text] [Related]
16. Human Blood CD1c+ Dendritic Cells Encompass CD5high and CD5low Subsets That Differ Significantly in Phenotype, Gene Expression, and Functions.
Yin X; Yu H; Jin X; Li J; Guo H; Shi Q; Yin Z; Xu Y; Wang X; Liu R; Wang S; Zhang L
J Immunol; 2017 Feb; 198(4):1553-1564. PubMed ID: 28087664
[TBL] [Abstract][Full Text] [Related]
17. Inflammatory Type 2 cDCs Acquire Features of cDC1s and Macrophages to Orchestrate Immunity to Respiratory Virus Infection.
Bosteels C; Neyt K; Vanheerswynghels M; van Helden MJ; Sichien D; Debeuf N; De Prijck S; Bosteels V; Vandamme N; Martens L; Saeys Y; Louagie E; Lesage M; Williams DL; Tang SC; Mayer JU; Ronchese F; Scott CL; Hammad H; Guilliams M; Lambrecht BN
Immunity; 2020 Jun; 52(6):1039-1056.e9. PubMed ID: 32392463
[TBL] [Abstract][Full Text] [Related]
18. Migratory CD11b
Krishnaswamy JK; Gowthaman U; Zhang B; Mattsson J; Szeponik L; Liu D; Wu R; White T; Calabro S; Xu L; Collet MA; Yurieva M; Alsén S; Fogelstrand P; Walter A; Heath WR; Mueller SN; Yrlid U; Williams A; Eisenbarth SC
Sci Immunol; 2017 Dec; 2(18):. PubMed ID: 29196450
[TBL] [Abstract][Full Text] [Related]
19. IRF8 Transcription Factor Controls Survival and Function of Terminally Differentiated Conventional and Plasmacytoid Dendritic Cells, Respectively.
Sichien D; Scott CL; Martens L; Vanderkerken M; Van Gassen S; Plantinga M; Joeris T; De Prijck S; Vanhoutte L; Vanheerswynghels M; Van Isterdael G; Toussaint W; Madeira FB; Vergote K; Agace WW; Clausen BE; Hammad H; Dalod M; Saeys Y; Lambrecht BN; Guilliams M
Immunity; 2016 Sep; 45(3):626-640. PubMed ID: 27637148
[TBL] [Abstract][Full Text] [Related]
20.
Theisen DJ; Ferris ST; Briseño CG; Kretzer N; Iwata A; Murphy KM; Murphy TL
Cancer Immunol Res; 2019 Jan; 7(1):29-39. PubMed ID: 30482745
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
